Antifungal Activities of Posaconazole, Ravuconazole, and Voriconazole Compared to Those of Itraconazole and Amphotericin B against 239 Clinical Isolates of Aspergillus spp. and Other Filamentous Fungi: Report from SENTRY Antimicrobial Surveillance Program, 2000

Benzer Materyaller

• Activities of Caspofungin, Itraconazole, Posaconazole, Ravuconazole, Voriconazole, and Amphotericin B against 448 Recent Clinical Isolates of Filamentous Fungi
  Yazar:: Diekema, D. J., ve diğerleri
  Baskı/Yayın Bilgisi: (2003)
• Germinated and Nongerminated Conidial Suspensions for Testing of Susceptibilities of Aspergillus spp. to Amphotericin B, Itraconazole, Posaconazole, Ravuconazole, and Voriconazole
  Yazar:: Espinel-Ingroff, A.
  Baskı/Yayın Bilgisi: (2001)
• In Vitro Activities of Ravuconazole and Voriconazole Compared with Those of Four Approved Systemic Antifungal Agents against 6,970 Clinical Isolates of Candida spp.
  Yazar:: Pfaller, M. A., ve diğerleri
  Baskı/Yayın Bilgisi: (2002)
• Multicenter Evaluation of a New Disk Agar Diffusion Method for Susceptibility Testing of Filamentous Fungi with Voriconazole, Posaconazole, Itraconazole, Amphotericin B, and Caspofungin
  Yazar:: Espinel-Ingroff, A., ve diğerleri
  Baskı/Yayın Bilgisi: (2007)
• Clinical Evaluation of a Frozen Commercially Prepared Microdilution Panel for Antifungal Susceptibility Testing of Seven Antifungal Agents, Including the New Triazoles Posaconazole, Ravuconazole, and Voriconazole
  Yazar:: Pfaller, M. A., ve diğerleri
  Baskı/Yayın Bilgisi: (2002)